Literature DB >> 19902338

Liquid perfluorocarbons as contrast agents for ultrasonography and (19)F-MRI.

Raquel Díaz-López1, Nicolas Tsapis, Elias Fattal.   

Abstract

Perfluorocarbons (PFCs) are fluorinated compounds that have been used for many years in clinics mainly as gas/oxygen carriers and for liquid ventilation. Besides this main application, PFCs have also been tested as contrast agents for ultrasonography and magnetic resonance imaging since the end of the 1970s. However, most of the PFCs applied as contrast agents for imaging were gaseous. This class of PFCs has been recently substituted by liquid PFCs as ultrasound contrast agents. Additionally, liquid PFCs are being tested as contrast agents for (19)F magnetic resonance imaging (MRI), to yield dual contrast agents for both ultrasonography and (19)F MRI. This review focuses on the development and applications of the different contrast agents containing liquid perfluorocarbons for ultrasonography and/or MRI: large and small size emulsions (i.e. nanoemulsions) and nanocapsules.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902338     DOI: 10.1007/s11095-009-0001-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  91 in total

Review 1.  Engineering blood: synthetic substitutes from fluorinated compounds.

Authors:  Kenneth C Lowe
Journal:  Tissue Eng       Date:  2003-06

2.  Oxygent: a novel probe of tissue oxygen tension.

Authors:  R P Mason; H Shukla; P P Antich
Journal:  Biomater Artif Cells Immobilization Biotechnol       Date:  1992

Review 3.  Ultrasound molecular imaging with targeted microbubble contrast agents.

Authors:  Alexander L Klibanov
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

4.  Application of Renyi entropy for ultrasonic molecular imaging.

Authors:  M S Hughes; J N Marsh; J M Arbeit; R G Neumann; R W Fuhrhop; K D Wallace; L Thomas; J Smith; K Agyem; G M Lanza; S A Wickline; J E McCarthy
Journal:  J Acoust Soc Am       Date:  2009-05       Impact factor: 1.840

Review 5.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

Review 6.  Ultrasound contrast agents: basic principles.

Authors:  F Calliada; R Campani; O Bottinelli; A Bozzini; M G Sommaruga
Journal:  Eur J Radiol       Date:  1998-05       Impact factor: 3.528

Review 7.  Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.

Authors:  Megan M Kaneda; Shelton Caruthers; Gregory M Lanza; Samuel A Wickline
Journal:  Ann Biomed Eng       Date:  2009-01-30       Impact factor: 3.934

8.  Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy.

Authors:  Zhonggao Gao; Anne M Kennedy; Douglas A Christensen; Natalya Y Rapoport
Journal:  Ultrasonics       Date:  2007-11-19       Impact factor: 2.890

9.  Non-invasive physiology: 19F NMR of perfluorocarbons.

Authors:  R P Mason
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  1994

10.  Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytotoxicity against cancer cells.

Authors:  Jia-You Fang; Chi-Feng Hung; Shu-Chiou Hua; Tsong-Long Hwang
Journal:  Ultrasonics       Date:  2008-05-07       Impact factor: 2.890

View more
  39 in total

1.  Delivery of water-soluble drugs using acoustically triggered perfluorocarbon double emulsions.

Authors:  Mario L Fabiilli; James A Lee; Oliver D Kripfgans; Paul L Carson; J Brian Fowlkes
Journal:  Pharm Res       Date:  2010-09-25       Impact factor: 4.200

2.  Screening of ligands for redox-active europium using magnetic resonance imaging.

Authors:  Brooke A Corbin; Lina A Basal; Susan A White; Yimin Shen; E Mark Haacke; Kenneth W Fishbein; Matthew J Allen
Journal:  Bioorg Med Chem       Date:  2018-04-04       Impact factor: 3.641

3.  Synthesis and characterization of perfluoro-tert-butyl semifluorinated amphiphilic polymers and their potential application in hydrophobic drug delivery.

Authors:  Sarah Decato; Troy Bemis; Eric Madsen; Sandro Mecozzi
Journal:  Polym Chem       Date:  2014-11-21       Impact factor: 5.582

4.  Enhancing Surface Capture and Sensing of Proteins with Low-Power Optothermal Bubbles in a Biphasic Liquid.

Authors:  Youngsun Kim; Hongru Ding; Yuebing Zheng
Journal:  Nano Lett       Date:  2020-07-21       Impact factor: 11.189

Review 5.  Echographic imaging of tumoral cells through novel nanosystems for image diagnosis.

Authors:  Marco Di Paola; Fernanda Chiriacò; Giulia Soloperto; Francesco Conversano; Sergio Casciaro
Journal:  World J Radiol       Date:  2014-07-28

6.  Lipid Shell Composition Plays a Critical Role in the Stable Size Reduction of Perfluorocarbon Nanodroplets.

Authors:  Steven K Yarmoska; Heechul Yoon; Stanislav Y Emelianov
Journal:  Ultrasound Med Biol       Date:  2019-04-08       Impact factor: 2.998

7.  Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent.

Authors:  Nashwa El-Gendy; Kristin L Aillon; Cory Berkland
Journal:  Int J Pharm       Date:  2010-03-07       Impact factor: 5.875

Review 8.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

9.  Acoustic droplet-hydrogel composites for spatial and temporal control of growth factor delivery and scaffold stiffness.

Authors:  Mario L Fabiilli; Christopher G Wilson; Frédéric Padilla; Francisco M Martín-Saavedra; J Brian Fowlkes; Renny T Franceschi
Journal:  Acta Biomater       Date:  2013-03-25       Impact factor: 8.947

10.  Assessment of the biodistribution of an [(18) F]FDG-loaded perfluorocarbon double emulsion using dynamic micro-PET in rats.

Authors:  Mario L Fabiilli; Morand R Piert; Robert A Koeppe; Phillip S Sherman; Carole A Quesada; Oliver D Kripfgans
Journal:  Contrast Media Mol Imaging       Date:  2013 Jul-Aug       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.